Home > Insider Trading > Filing (0001209191-20-016765)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1340652	Chemocentryx Inc.	CCXI	Pharmaceutical Preparations (2834)	943254365

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1423084	J. Thomas Schall	C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-03-04	40,844	$14.31	2,309,401	No	4	M	Direct
Common Stock	Disposition	2020-03-04	40,844	$50.35	2,268,557	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-03-04	40,844	$0.00	40,844	$14.31
Common Stock	Restricted Stock Units	Acquisiton	2020-03-03	103,700	$0.00	103,700	$0.00
Common Stock	Stock Option (right to buy)	Acquisiton	2020-03-03	71,500	$0.00	71,500	$46.59

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
246,038	2022-07-24	No	4	M	Direct
103,700		No	4	A	Direct
71,500	2030-03-03	No	4	A	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $49.99 to $50.83 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
As of March 4, 2020, and prior to this transaction, the exercised options were fully vested.
Not applicable.
Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
The restricted stock units awarded on March 3, 2020, vest in three equal installments on January 1, 2021, January 1, 2022, and January 1, 2023, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.
The option was granted on March 3, 2020, and 25% of the total number of shares of common stock subject to the option vests on January 1, 2021, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date.